Severity
Moderate
FDA Drug recall · Reported July 31, 2019
Microbial Contamination of Non-Sterile Products and Superpotent Drug: FDA analysis revealed microbial contamination in addition to high out of specification results for iron conte…
Dercher Enterprises, Inc., DBA Gordon Laboratories recalled MONSEL'S (Ferric Subsulfate) Solution, 8 mL amber glass bottle, packaged as one dozen bot… - a moderate-severity action.
MONSEL'S (Ferric Subsulfate) Solution, 8 mL amber glass bottle, packaged as one dozen bot… was recalled by Dercher Enterprises, Inc., DBA Gordon Laboratories in July 31, 2019. Reason: Microbial Contamination of Non-Sterile Products and Superpotent Drug: FDA analysis revealed microbial contami…. Check the official notice for the remedy. Verify recall #D-1528-2019 with the FDA Drug before acting.
The recall
Dercher Enterprises, Inc., DBA Gordon Laboratories issued this moderate-severity FDA Drug recall-Microbial Contamination of Non-Sterile Products and Superpotent Drug: FDA analysis revealed microbial contami….
Sourced from official FDA Drug enforcement records. Verify recall #D-1528-2019 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1528-2019) was formally reported on July 31, 2019, with the manufacturer initiating the action on July 19, 2019. It is classified under Moderate severity (Class II), with a current status of Terminated. Dercher Enterprises, Inc., DBA Gordon Laboratories is listed as the recalling firm, operating out of Upper Darby, PA. Federal records list the affected scope as 277 boxes.
The documented reason for this recall is: Microbial Contamination of Non-Sterile Products and Superpotent Drug: FDA analysis revealed microbial contamination in addition to high out of specification results for iron content. Distribution data in the federal record shows the product reached: Nationwide in the USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
277 boxes
Related Recalls
6
5 from same agency
MONSEL'S (Ferric Subsulfate) Solution, 8 mL amber glass bottle, packaged as one dozen bottles with applicators per box, Rx only, Gordon Laboratories, Upper Darby, PA 19082, NDC 10481-0112-8.
Microbial Contamination of Non-Sterile Products and Superpotent Drug: FDA analysis revealed microbial contamination in addition to high out of specification results for iron content.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-1528-2019 |
| Date reported | July 31, 2019 |
| Date initiated | July 19, 2019 |
| Recalling firm | Dercher Enterprises, Inc., DBA Gordon Laboratories |
| Firm location | Upper Darby, PA |
| Affected scope | 277 boxes |
| Distribution | Nationwide in the USA |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported July 31, 2019. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.